In conclusion, our findings uncover that the up-regulation of CEMIP mediated by TP53 mutation, DNA hypomethylation, and transcription factors correlates with worse outcomes and higher immune cell infiltration levels of patients with BC. The gene discussed is CEMIP; the disease is breast cancer.